Foresite Capital Management II’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $7.9M | Hold |
|
|||||
|
2021
Q2 | $5.76M | Hold |
|
|||||
|
2021
Q1 | $6.22M | Hold |
|
|||||
|
2020
Q4 | $5.87M | Hold |
|
|||||
|
2020
Q3 | $5.16M | Buy |
|
|||||
|
2020
Q2 | $3.31M | Hold |
|
|||||
|
2020
Q1 | $3.13M | Sell |
|
|||||
|
2019
Q4 | $10M | Hold |
|
|||||
|
2019
Q3 | $7.45M | Hold |
|
|||||
|
2019
Q2 | $7.75M | Hold |
|
|||||
|
2019
Q1 | $8.78M | Sell |
|
|||||
|
2018
Q4 | $9.13M | Sell |
|
|||||
|
2018
Q3 | $12.6M | Sell |
|
|||||
|
2018
Q2 | $11.9M | Hold |
|
|||||
|
2018
Q1 | $9.57M | Hold |
|
|||||
|
2017
Q4 | $10.4M | Hold |
|
|||||
|
2017
Q3 | $9.13M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $527K | Hold |
|
|||||
|
2016
Q4 | $508K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.66M | Sell |
|
|||||
|
2016
Q1 | $4.59M | Buy |
|
|||||
|
2015
Q4 | $6.7M | Sell |
|
|||||
|
2015
Q3 | $4.95M | Buy |
|
|||||
|
2015
Q2 | $984K | Buy |
|